Cholera Outbreak: Situation Report #28 – July 24, 2025
Table of Contents
As of July 24,2025,the world continues to grapple with a meaningful cholera upsurge,a stark reminder of the persistent threat posed by this preventable and treatable disease. Between January 1 and June 29, 2025, a staggering 305,903 cholera cases and 3,522 deaths were reported across 28 countries spanning three World Health Association (WHO) regions. The Eastern mediterranean Region bore the brunt of this crisis, followed closely by the African Region and the South-East Asia Region. while other WHO regions remained unaffected during this period, the global impact underscores the urgent need for robust public health strategies. Even in June 2025, with a reported decrease in new cases and deaths compared to the previous month, the global oral Cholera Vaccine (OCV) stockpile dipped below the critical emergency level of five million doses for the first time in six months, highlighting the ongoing challenges in maintaining adequate preparedness.
This article serves as a definitive, evergreen resource, delving into the complexities of the current cholera situation, outlining essential prevention strategies, detailing effective response mechanisms, and exploring the critical elements of future preparedness. Drawing upon the latest data and expert insights,we aim to equip individuals,communities,and health organizations with the knowledge necessary to combat this persistent public health threat.
Understanding Cholera: The Silent Killer
Cholera is an acute diarrheal illness caused by infection of the intestine with Vibrio cholerae bacteria. The bacteria are typically ingested through contaminated food or water.While often associated with areas lacking adequate sanitation and safe drinking water, cholera can emerge in any setting where these conditions are compromised, including during natural disasters or humanitarian crises.
The Pathogen and Its Transmission
Vibrio cholerae exists in various serogroups, but only O1 and O139 are known to cause epidemics. The bacteria thrive in environments with poor sanitation, where fecal matter can contaminate water sources. Once ingested,the bacteria multiply in the small intestine,releasing a toxin that causes severe,watery diarrhea and vomiting. This rapid fluid loss can lead to severe dehydration, shock, and, if left untreated, death within hours.
Symptoms and Severity
The incubation period for cholera is typically very short, ranging from a few hours to five days. Symptoms can vary from mild to severe. The hallmark symptom is profuse, painless, watery diarrhea, often described as “rice-water stool.” Other common symptoms include:
Vomiting: Can be severe and persistent.
Dehydration: Characterized by thirst, dry mouth, sunken eyes, reduced urination, and lethargy.
Electrolyte Imbalance: Leading to muscle cramps and weakness.In severe cases, rapid dehydration can lead to hypovolemic shock, characterized by a rapid, weak pulse, low blood pressure, and decreased consciousness. Prompt rehydration is crucial for survival.
The Current Cholera Landscape: Trends and Challenges
The global cholera situation from January 1 to June 29, 2025, paints a concerning picture. The cumulative data reveals a widespread and persistent outbreak, with the Eastern Mediterranean Region reporting the highest burden. The decrease in cases and deaths observed in June 2025 offers a glimmer of hope, but the underlying vulnerabilities remain.
Regional hotspots and Data Analysis
The concentration of cases in the Eastern Mediterranean, African, and South-East Asia regions highlights the critical need for targeted interventions in these areas. Factors contributing to the high incidence in these regions often include:
Weak Public Health Infrastructure: limited access to clean water, sanitation facilities, and healthcare services.
Conflict and Displacement: Humanitarian crises often disrupt essential services and create conditions conducive to cholera transmission.
Climate Change: Extreme weather events, such as floods and droughts, can contaminate water sources and exacerbate outbreaks.The decrease in new cases in June 2025, while positive, must be viewed with caution. It might very well be a temporary lull, and sustained efforts are required to prevent resurgence.
The Oral Cholera Vaccine (OCV) Stockpile Dilemma
The decline in the OCV stockpile below the emergency threshold of five million doses in June 2025 is a critical concern. the OCV is a vital tool in cholera prevention and control, particularly in outbreak settings and for vulnerable populations. Maintaining an adequate and readily accessible stockpile is paramount for rapid response. This situation underscores the challenges in global vaccine manufacturing, equitable distribution, and the need for increased investment in cholera preparedness.
##